17133-54-9

Basic information

• Product Name: (3,4-Dihydro-2H-quinolin-1-yl)-acetic acid Methyl ester
• Synonyms: (3,4-Dihydro-2H-quinolin-1-yl)-acetic acid Methyl ester;Methyl 2-(3,4-dihydroquinolin-1(2H)-yl)acetate
• CAS NO: 17133-54-9
• Molecular Formula: C12H15NO2
• Molecular Weight: 205.253
• Mol File: 17133-54-9.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: (3,4-Dihydro-2H-quinolin-1-yl)-acetic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (3,4-Dihydro-2H-quinolin-1-yl)-acetic acid Methyl ester(17133-54-9)
• EPA Substance Registry System: (3,4-Dihydro-2H-quinolin-1-yl)-acetic acid Methyl ester(17133-54-9)

Safety Data

• Hazardous Substances Data: 17133-54-9(Hazardous Substances Data)

Usage

General Description

(3,4-Dihydro-2H-quinolin-1-yl)-acetic acid Methyl ester is a chemical compound that belongs to the class of quinoline derivatives. It is a methyl ester of (3,4-Dihydro-2H-quinolin-1-yl)-acetic acid, which is a synthetic intermediate used in the production of pharmaceuticals and agrochemicals. (3,4-Dihydro-2H-quinolin-1-yl)-acetic acid Methyl ester has potential pharmacological activities and is under study for its potential use as a drug candidate. It has a quinoline backbone, which is known for its diverse biological activities and is being investigated for its therapeutic potential in various diseases. Overall, (3,4-Dihydro-2H-quinolin-1-yl)-acetic acid Methyl ester is a chemical with potential pharmaceutical applications and is the subject of ongoing research and development.

Upstream product

• 635-46-1 1,2,3,4-tetrahydroisoquinoline 
• 96-32-2 bromoacetic acid methyl ester 
• 108-59-8 malonic acid dimethyl ester 
• 16695-14-0 Malonic acid monomethyl ester 
• 96-34-4 methyl chloroacetate 
• 767-92-0 decahydroquinoline 

Relevant articles and documents

Inactivation of myostatin by photo-oxygenation using catalyst-functionalized peptides

Inhibition of myostatin is an attractive treatment for muscular dystrophy and other amyotrophic diseases. A myostatin-binding peptide was functionalized by equipped with an on/off switchable photo-oxygenation catalyst. This peptide induces a selective oxygenation of myostatin under near-infrared light, resulting in inactivation of myostatin. This peptide shows several orders of magnitude greater inhibitory effect than the original peptide.

Transition-metal-free decarboxylation of dimethyl malonate: An efficient construction of α-amino acid esters using TBAI/TBHP

A transition-metal-free decarboxylation coupling process for the preparation of α-amino acid esters, which succeeded in merging hydrolysis/decarboxylation/nucleophilic substitution, is well described. This strategy uses commercially available inexpensive starting materials, catalysts and oxidants and has a wide substrate scope and operational simplicity. This journal is

Pharmaceutical compounds

This invention relates to compounds of formula (I) where R1 to R12, —W—V—, —X—Y—, m and n have the values defined in claim 1, their preparation and use as pharmaceuticals.